miR-370-3p as a Novel Biomarker Promotes Breast Cancer Progression by Targeting FBLN5

Table 2

Correlation between miR-370-3p in breast cancer tissues and clinicopathological parameters.

Clinicopathological information	n	Relative expression of miR-370-3p	P
Tumor diameter
<=2cm	18	6.371(1.450, 58.84)	0.1864
>2cm	13	2.389(0.696, 12.60)
Age
<=50	8	2.383(1.432, 16.83)	0.4701
>50	23	6.951(1.428, 28.49)
Pathological type
Ductal carcinoma in situ	3	1.428(0.068, 28.49)	0.5331
Invasive ductal carcinoma	18	5.507(1.500, 87.45)
Mucinous adenocarcinoma	2	2.781(1.033, 3.139)
Others	8	6.549(1.405, 31.13)
Lymph node metastasis
0	25	3.506(1.350, 14.18)	0.0483
>=1	6	18.32(6.029, 285.1)
TNM staging
I	14	2.781(1.350, 20.94)	0.5515
II	17	6.951(1.249, 33.85)
ER
-	10	1.439(0.067, 87.44)	0.1631
+	21	6.951 (2.167, 25.76)
PR
-	10	2.478 (0.067, 166.8)	0.6420
+	21	5.792 (1.500, 15.05)
HER-2
-	3	0.711 (0.062, 1.500)	0.6175
+	6	0.541 (1.339, 32.54)
++	15	5.792 (2.389, 11.78)
+++	6	39.21 (0.968, 87.44)